CD8A and neoplasm: Cisplatin induces an increase in CCL20 and IL-1β in tumor cells within a cold tumor model, both of which activate ILC3s to release the chemokine CXCL10, attracting CD4 T and CD8 T lymphocytes to infiltrate tumor tissue and then exert anti-tumor effects (153).